% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Heinzel:908587,
      author       = {Heinzel, Alexander and Dedic, Daniela and Galldiks, Norbert
                      and Lohmann, Philipp and Stoffels, Gabriele and Filss,
                      Christian P. and Kocher, Martin and Migliorini, Filippo and
                      Dillen, Kim N. H. and Geisler, Stefanie and Stegmayr, Carina
                      and Willuweit, Antje and Sabel, Michael and Rapp, Marion and
                      Eble, Michael J. and Piroth, Marc and Clusmann, Hans and
                      Delev, Daniel and Bauer, Elena K. and Ceccon, Garry and
                      Dunkl, Veronika and Rosen, Jurij and Tscherpel, Caroline and
                      Werner, Jan-Michael and Ruge, Maximilian I. and Goldbrunner,
                      Roland and Hampl, Jürgen and Weiss Lucas, Carolin and
                      Herrlinger, Ulrich and Maurer, Gabriele D. and Steinbach,
                      Joachim P. and Mauler, Jörg and Worthoff, Wieland A. and
                      Neumaier, Bernd N. and Lerche, Christoph and Fink, Gereon
                      Rudolf and Shah, N. J. and Mottaghy, Felix M. and Langen,
                      Karl-Josef},
      title        = {{T}wo {D}ecades of {B}rain {T}umour {I}maging with
                      {O}-(2-[18{F}]fluoroethyl)-{L}-tyrosine {PET}: {T}he
                      {F}orschungszentrum {J}ülich {E}xperience},
      journal      = {Cancers},
      volume       = {14},
      number       = {14},
      issn         = {2072-6694},
      address      = {Basel},
      publisher    = {MDPI},
      reportid     = {FZJ-2022-02703},
      pages        = {3336 -},
      year         = {2022},
      abstract     = {PET using radiolabelled amino acids has become an essential
                      tool for diagnosing brain tumours in addition to MRI.
                      O-(2-[18F]fluoroethyl)-L-tyrosine (FET) is one of the most
                      successful tracers in the field. We analysed our database of
                      6534 FET PET examinations regarding the diagnostic needs and
                      preferences of the referring physicians for FET PET in the
                      clinical decision-making process. The demand for FET PET
                      increased considerably in the last decade, especially for
                      differentiating tumour progress from treatment-related
                      changes in gliomas. Accordingly, referring physicians rated
                      the diagnostics of recurrent glioma and recurrent brain
                      metastases as the most relevant indication for FET PET. The
                      analysis and survey results confirm the high relevance of
                      FET PET in the clinical diagnosis of brain tumours and
                      support the need for approval for routine use.},
      cin          = {INM-4 / INM-11 / JARA-BRAIN / INM-3 / INM-5},
      ddc          = {610},
      cid          = {I:(DE-Juel1)INM-4-20090406 / I:(DE-Juel1)INM-11-20170113 /
                      I:(DE-Juel1)VDB1046 / I:(DE-Juel1)INM-3-20090406 /
                      I:(DE-Juel1)INM-5-20090406},
      pnm          = {5253 - Neuroimaging (POF4-525)},
      pid          = {G:(DE-HGF)POF4-5253},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {35884396},
      UT           = {WOS:000831654800001},
      doi          = {10.3390/cancers14143336},
      url          = {https://juser.fz-juelich.de/record/908587},
}